•
Junovabio, a Shanghai-based molecular diagnostics specialist, has reportedly raised “tens of millions” of renminbi in a Pre-Series A financing round. The round was led by Shenzhen Jinsheng Equity Investment Management Co., Ltd. The proceeds will be used for the clinical filing of its first tumor molecular diagnosis product, product clinical…